Company Filing History:
2 out of 633 
2 out of 2 Years Active: 2021-2025
Title: Innovations of Steven Thng in Therapeutic Delivery Systems
Introduction
Steven Thng is an accomplished inventor based in Singapore, SG. He has made significant contributions to the field of therapeutic delivery systems, particularly focusing on melanocyte-targeting technologies. With a total of 2 patents, his work has the potential to impact the treatment of various skin disorders.
Latest Patents
One of Steven Thng's latest patents is titled "Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages." This invention relates to protein nanocages that comprise a melanocyte-targeting moiety and pharmaceutical compositions that utilize these protein cages. The methods described in this patent aim to treat or diagnose hyperpigmentation disorders and other melanocyte-related conditions. The preferred embodiment of the protein nanocage is composed of the E2 protein from the pyruvate dehydrogenase multi-enzyme complex, which includes a skin-penetrating and cell-permeating moiety, along with a melanocyte-targeting moiety derived from alpha melanocyte-stimulating hormone.
Career Highlights
Throughout his career, Steven Thng has worked with notable institutions such as Nanyang Technological University and the National Skin Center Pte Ltd. His experience in these organizations has allowed him to develop innovative solutions in the field of dermatology and therapeutic delivery.
Collaborations
Steven has collaborated with esteemed colleagues, including Sierin Lim and Sathyamoorthy Bhaskar. These partnerships have further enriched his research and development efforts.
Conclusion
In summary, Steven Thng is a prominent inventor whose work in melanocyte-targeting technologies has the potential to revolutionize the treatment of skin disorders. His innovative patents and collaborations highlight his commitment to advancing therapeutic delivery systems.